Cost effectiveness analysis of asciminib in patients with chronic phase chronic myeloid leukemia previously treated with 2 or more tyrosine kinase inhibitors in Colombia
Ceballos M et al. Value Health Reg Issues, September 2026 (epub ahead of print)
Link to full abstract